Skip to main content
Clinical Trials/NCT04263857
NCT04263857RecruitingNot Applicable

Register of Survey and Evaluation of Blood Stem Cell Transplantations of Clinic III of Internal Medicine III

Technical University of Munich1 site in 1 country5,000 target enrollmentStarted: November 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
5,000
Locations
1
Primary Endpoint
Register of stem cell transplantation

Study Overview

Brief Summary

Register of patients with blood stem cell transplantations (autologous, allogen).

Detailed Description

Documenting the success rate in terms of complication rate, disease response, survival rate, engraftment, and details of transplantation settings, for example donor and conditioning data, remission status before transplantation.

It's a register of patients who have one or more autologous and / or allogenic blood stem cell transplants due to an existing indication for performing myeloablative / non-myeloablative high-dose chemotherapy.

The inclusion occurs at our center during preparation for blood stem cell transplantation. The written consent will be obtained separately in the context of the information on blood stem cell transplantation. Participation is voluntary and consent can be revoked at any time. This involves no additional effort for the patient and has no influence on his treatment. It may be necessary in the course of contacting the patient at home, as long as the data is incomplete. This is also explicitly explained. A copy of the declaration of consent is given to the patient.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •signed IC
  • •patients eligible for stem cell transplantation

Exclusion Criteria

  • •unable to consent to study participation

Outcomes

Primary Outcomes

Register of stem cell transplantation

Time Frame: approximately over 20 years

Recording of all stem cell transplantations over many years

Secondary Outcomes

  • Register of survivals(approximately over 20 years)
  • Register of toxicities(approximately over 20 years)
  • Register of complications(approximately over 20 years)
  • Register of morbidities(approximately over 20 years)

Investigators

Sponsor
Technical University of Munich
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials